Murray M. Bern

Guidelines on oral anticoagulation: third edition

Effect of Clopidogrel Added to Aspirin in Patients with Atrial Fibrillation

Primary thromboprophylaxis for cancer patients with central venous catheters – a reappraisal of the evidence

Gastric cancer

Double-blind randomised trial of very-low-dose warfarin for prevention of thromboembolism in stage IV breast cancer

Thrombin Stimulates Neutrophil Adherence by an Endothelial Cell‐Dependent Mechanism: Characterization of the Response and Relationship to Platelet‐Activating Factor Synthesis^a

Pharmacology and Management of the Vitamin K Antagonists

Postoperative Irradiation with or without Concomitant Chemotherapy for Locally Advanced Head and Neck Cancer

Perioperative Chemotherapy versus Surgery Alone for Resectable Gastroesophageal Cancer

Central Vein Catheter-Related Thrombosis in Intensive Care Patients

A Clinical Trial of Vena Caval Filters in the Prevention of Pulmonary Embolism in Patients with Proximal Deep-Vein Thrombosis

Long-Term, Low-Intensity Warfarin Therapy for the Prevention of Recurrent Venous Thromboembolism

Prognosis of Cancers Associated with Venous Thromboembolism

Efficacy of Combined Modality Prophylaxis Including Short-Duration Warfarin to Prevent Venous Thromboembolism After Total Hip Arthroplasty

A phase II study in advanced gastro-esophageal cancer using epirubicin and cisplatin in combination with continuous infusion 5-fluorouracil (ECF)

Risk factors for catheter-related thrombosis in cancer patients

Randomized trial comparing epirubicin, cisplatin, and fluorouracil versus fluorouracil, doxorubicin, and methotrexate in advanced esophagogastric cancer.

Paraneoplastic Syndromes Involving the Nervous System

Benefit of Heparin in Central Venous and Pulmonary Artery Catheters

Uremic Bleeding: Pathogenesis and Therapy

Validation of Clinical Classification Schemes for Predicting Stroke

Emergency Hospitalizations for Adverse Drug Events in Older Americans

Esophageal Cancer

A prospective analysis of 949 long-term central venous access catheters for ambulatory chemotherapy in patients with gastrointestinal malignancy

The Management of Thrombosis in the Antiphospholipid-Antibody Syndrome

Catheter-Related Thrombosis in Cancer Patients: Pathophysiology, Diagnosis, and Management

Prevention of central venous line-related thrombosis by continuous infusion of low-dose unfractionated heparin, in patients with haemato-oncological disease

Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study

Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism

Platelet Activation and Atherothrombosis

Prevention of central venous catheter associated thrombosis using minidose warfarin in patients with haematological malignancies

Dalteparin for prevention of catheter-related complications in cancer patients with central venous catheters: final results of a double-blind, placebo-controlled phase III trial

Effectiveness of fixed minidose warfarin in the prevention of thromboembolism and vascular death in nonrheumatic atrial fibrillation∗∗The investigators and institutions participating in the study are listed in the Appendix.

The Antiphospholipid Syndrome

Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention

Diabetes and Atherosclerosis

A Prospective Study of Venous Thromboembolism after Major Trauma

Oral Anticoagulants

Prevention of Venous Thromboembolism

Low-Molecular-Weight Heparin versus a Coumarin for the Prevention of Recurrent Venous Thromboembolism in Patients with Cancer

Current Practices in the Prophylaxis of Venous Thromboembolism in Bariatric Surgery

Free radicals and antioxidants in normal physiological functions and human disease

Hemostatic alterations in cancer patients

Oral Anticoagulants: Mechanism of Action, Clinical Effectiveness, and Optimal Therapeutic Range

Rivaroxaban versus Enoxaparin for Thromboprophylaxis after Hip Arthroplasty

Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial

Cancer and venous thromboembolism

Thrombosis Prophylaxis in Patient Populations With a Central Venous Catheter

Prevention of Venous Thromboembolism

Biochemistry and molecular cell biology of diabetic complications

Central venous catheter—related blood stream infections: incidence, risk factors, outcome, and associated pathogens

Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation

Femoral deep vein thrombosis associated with central venous catheterization

Disseminated Intravascular Coagulation

The Pharmacology and Management of the Vitamin K Antagonists

Antithrombotic Therapy for Venous Thromboembolic Disease

An Analysis of the Lowest Effective Intensity of Prophylactic Anticoagulation for Patients with Nonrheumatic Atrial Fibrillation

Capecitabine and Oxaliplatin for Advanced Esophagogastric Cancer

Chlorhexidine and silver-sulfadiazine coated central venous catheters in haematological patients—a double-blind, randomised, prospective, controlled trial

Prevention of venous thrombosis with minidose warfarin after joint replacement.

Anticoagulation for thrombosis prophylaxis in cancer patients with central venous catheters

Deep vein thrombosis

Amyloid β-peptide is produced by cultured cells during normal metabolism

Hemorrhagic Complications of Anticoagulant Treatment

Guidelines for the Prevention of Intravascular Catheter-related Infections

A Comparison of Enoxaparin with Placebo for the Prevention of Venous Thromboembolism in Acutely Ill Medical Patients

An Intervention to Decrease Catheter-Related Bloodstream Infections in the ICU

Hemorrhagic Complications of Anticoagulant Treatment

Burden of endemic health-care-associated infection in developing countries: systematic review and meta-analysis

Prevention of Venous Thromboembolism

Hemorrhagic Complications of Anticoagulant Treatment

Chlorhexidine–Alcohol versus Povidone–Iodine for Surgical-Site Antisepsis

Mechanisms of thrombogenesis in atrial fibrillation: Virchow's triad revisited

Management of Anticoagulation before and after Elective Surgery

Does Paclitaxel Improve the Chemoradiotherapy of Locoregionally Advanced Esophageal Cancer? A Nonrandomized Comparison With Fluorouracil-Based Therapy

Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial

Venous thromboembolic complications (VTE) in children: first analyses of the Canadian Registry of VTE

Deep vein thrombosis associated with central venous catheters – a review

Minidose Warfarin and Failure to Prevent Deep Vein Thrombosis After Joint Replacement Surgery Despite Inhibiting the Postoperative Rise in Plasminogen Activator Inhibitor Activity

Preventing Complications of Central Venous Catheterization

Prevention of Venous Thromboembolism

American Heart Association/American College of Cardiology Foundation Guide to Warfarin Therapy

Hyperglycemia Potentiates Collagen-Induced Platelet Activation Through Mitochondrial Superoxide Overproduction

Clinical Trials on Antiphospholipid Syndrome: What is Being Done and What is Needed?

Central venous device-related infection and thrombosis in patients treated with moderate dose continuous-infusion interleukin-2

ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease

Effects of Fixed Low-Dose Warfarin, Aspirin-Warfarin Combination Therapy, and Dose-Adjusted Warfarin on Thrombogenesis in Chronic Atrial Fibrillation

American Heart Association/American College of Cardiology Foundation guide to warfarin therapy11The American Heart Association makes every effort to avoid any actual or potential conflicts of interest that may arise as a result of an outside relationship or a personal, professional, or business interest of a member of the writing panel. Specifically, all members of the writing group are required to complete and submit a Disclosure Questionnaire showing all such relationships that might be perceived as real or potential conflicts of interest.This statement has been co-published in the April 1, 2003, issue of Circulation.This statement was approved by the American Heart Association Science Advisory and Coordinating Committee in October 2002 and by the American College of Cardiology Board of Trustees in February 2003. A single reprint is available by calling 800-242-8721 (US only) or writing the American Heart Association, Public Information, 7272 Greenville Ave, Dallas, TX 75231-4596. Ask for reprint No. 71-0254. To purchase additional reprints: up to 999 copies, call 800-611-6083 (US only) or fax 413-665-2671; 1000 or more copies, call 410-528-4426, fax 410-528-4264, or e-mail klbradle@lww.com. To make photocopies for personal or educational use, call the Copyright Clearance Center, 978-750-8400.

Low-molecular-weight heparin (nadroparin) and very low doses of warfarin in the prevention of upper extremity thrombosis in cancer patients with indwelling long-term central venous catheters: a pilot randomized trial.

The relationship between inhibition of vitamin K1 2,3‐epoxide reductase and reduction of clotting factor activity with warfarin.

Prevention of Intravascular Catheter–Related Infections

Enoxaparin for the Prevention of Venous Thromboembolism Associated With Central Vein Catheter: A Double-Blind, Placebo-Controlled, Randomized Study in Cancer Patients

Platelet hyperactivity and abnormal Ca²⁺homeostasis in diabetes mellitus

Ferroptosis as a target for protection against cardiomyopathy

COAGULATION DISORDERS IN CANCER

Characterization of a new megakaryocytic cell line: the Dami cell

Optimal Therapeutic Range for Oral Anticoagulants

Low-Molecular-Weight Heparins

Disseminated intravascular coagulation due to malignancy.

Hemorrhagic Complications of Anticoagulant Treatment

Reduction of factor VII coagulant activity (VIIC), a risk factor for ischaemic heart disease, by fixed dose warfarin: a double blind crossover study.

Prevention of Venous Thromboembolism

The Anthracycline Antineoplastic Drugs

Interactions of Warfarin with Drugs and Food

Venous Thrombosis in Cancer Patients: Insights from the FRONTLINE Survey

Venous thrombosis: a multicausal disease

Tumors: Wounds That Do Not Heal

Fixed minidose warfarin: a new approach to prophylaxis against venous thrombosis after major surgery.

Assessment of venous thromboembolism risk and the benefits of thromboprophylaxis in medical patients

Randomized Placebo-Controlled Study of Low-Dose Warfarin for the Prevention of Central Venous Catheter–Associated Thrombosis in Patients With Cancer

Minidose (1 mg) warfarin as prophylaxis for central vein catheter thrombosis

Fibrin d -Dimer and β-Thromboglobulin as Markers of Thrombogenesis and Platelet Activation in Atrial Fibrillation

Antithrombotic Therapy for Venous Thromboembolic Disease

The Effect of Low-Dose Warfarin on the Risk of Stroke in Patients with Nonrheumatic Atrial Fibrillation

Thrombotic Complications of Central Venous Catheters in Cancer Patients

Minidose Warfarin Prophylaxis for Catheter-Associated Thrombosis in Cancer Patients: Can It Be Safely Associated With Fluorouracil-Based Chemotherapy?

Combined paclitaxel, cisplatin, and etoposide for patients with previously untreated esophageal and gastroesophageal carcinomas

Very Low Doses of Warfarin Can Prevent Thrombosis in Central Venous Catheters

Four patients with myelodysplastic syndrome with translocation (1;7)(p11;p11) including one patient with independent clones del(1)(q22) and t(1;7)(q21;q11)

Very low dose warfarin as prophylaxis against ultrasound detected deep vein thrombosis following primary hip replacement

Response of Protein C and Protein C inhibitor to warfarin therapy in patient with combined deficiency of factors V and VIII

Prophylaxis against central vein thrombosis with low-dose warfarin.

Effect on platelet function of hypoalbuminemia in peritoneal dialysis

Low Antithrombin III in Morbid Obesity: Return to Normal with Weight Reduction

Bleomycin-induced fatal hyperpyrexia

Platelet Functions in Diabetes Mellitus

Cultured endothelial cells derived from the human iliac arteries

Intraarterial hepatic infusion and intravenous adriamycin for treatment of hepatocellular carcinoma.A clinical and pharmacology report